Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
Clinical trial NCT01581060 · TERMINATED
Trial details
- NCT number
- NCT01581060
- Sponsor
- Heidelberg Pharma AG
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2014-04-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.